Loading...

COGT COGENT BIOSCIENCES INC Investments/Divestments 8-K Filing

CGNT

CGT

COGENT BIOSCIENCES INC

(COGT)

2023 8-K

Show Summary

Summary

Equity Offerings

Product Expansion

Debt-Equity Swaps

Financial Statements

Financial Results

Clinical Trial Update

Financial Results

Clinical Trial Updates

Financial Results Announcement

FDA Alignment Announcement

Annual Meeting and Amendmen...

Earnings Reports

Unregistered Sales of Equit...

Financial Results Announcement

Private Placement

Positive Clinical Trial Dat...

Earnings Reports

Earnings Reports

Underwriting Agreement

Annual Meeting Approval

Positive Phase 3 PEAK trial...

Earnings Reports

Earnings Reports

External Links:

Cogent Biosciences announced positive data from its Phase 3 PEAK trial for bezuclastinib in GIST patients, with encouraging safety and clinical activity results.

AI Assistant

COGENT BIOSCIENCES INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.